Skip to main content
SpringerLink
Log in

Diabetes Mellitus and Glucagonoma

  • Chapter
Cutaneous Manifestations of Endocrine Diseases

  • 937 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Abdollahi Daneshpazhooh M, Amirchaghmaghi E, Sheikhi S, Eshrati B, Bastanhagh. Dermop-athy and retinopathy in diabetes: is there an association? Dermatology. 2007;214(2):133–6.

    PubMed  Google Scholar 

  • Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P. Increased prevalence of micro-vascular complications in type 2 diabetes patients with the metabolic syndrome. Israel Med Assoc J. 2006;8(6):378–82.

    Google Scholar 

  • Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endo-crinol (Oxf). 2002;57(6):827–31.

    Article  Google Scholar 

  • Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg. 2005;9(6):296–302.

    Article  PubMed  Google Scholar 

  • Al-Khenaizan S, Al Thubaiti M, Al Alwan I. Lispro insulin-induced lipoatrophy: a new case. Pedi-atr Diabetes. 2007;8(6):393–6.

    Article  Google Scholar 

  • Amon-Herzig-Kellerer. Antidiabetica. Wissenschaftliche Verlagsgesellschaft, Stuttgart 2000.

    Google Scholar 

  • Arranz A, Andia V, López-Guzmán A. A case of lipoatrophy with Lispro insulin without insulin pump therapy. Diabetes Care. 2004;27(2):625–6.

    Article  PubMed  Google Scholar 

  • Aslan E, Körber A, Grabbe S, Dissemond J. Erfolgreiche Therapie einer exulzerierten Necrobiosis lipoidica non diabeticorum mit Ciclosporin. Hautarzt. 2007;58(8):684–8.

    Article  PubMed  CAS  Google Scholar 

  • Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum. 2006;35(6):355–9.

    Article  PubMed  Google Scholar 

  • Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes. Horm Res. 2006;65(5):253–60.

    Article  PubMed  CAS  Google Scholar 

  • Bewley A P, Ross JS, Bunker CB, Staughton RC. Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema. Br J Dermatol. 1996;134(6):1101–4.

    Article  PubMed  CAS  Google Scholar 

  • Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, Carrillo T. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy. 1996;51(6):421–4.

    PubMed  CAS  Google Scholar 

  • Bodtger U, Wittrup M. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med. 2005;22(1):102–6.

    Article  PubMed  CAS  Google Scholar 

  • Bowen AR, Smith L, Zone JJ. Scleredema adultorum of Buschke treated with radiation. Arch Dermatol. 2003;139(6):780–4.

    Article  PubMed  Google Scholar 

  • Boyd AS. Treatment of necrobiosis lipoidica with pioglitazone. J Am Acad Dermatol. 2007;57 (5 Suppl):S120–1.

    Article  PubMed  Google Scholar 

  • Brownlee M, Aiello L P, Friedman E, Vinik AI, Nesto RW, Boulton JM. Complications of diabetes mellitus, pp 1509–84. In: Williams Textbook of Endocrinology, 10th Edition, Eds: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Saunders, Philadelphia, 2003

    Google Scholar 

  • Camisa C. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology. Arch Dermatol. 1989;125(3):407–12.

    Article  PubMed  CAS  Google Scholar 

  • Case CC, Vassilopoulou-Sellin R. Reproduction of features of the glucagonoma syndrome with continuous intravenous glucagon infusion as therapy for tumor-induced hypoglycemia. Endocr Pract. 2003;9(1):22–5.

    PubMed  Google Scholar 

  • Castera V, Dutour-Meyer A, Koeppel M, Petitjean C, Darmon P. Systemic allergy to human insulin and its rapid and long acting analogs:successful treatment by continuous subcutaneous insulin lispro infusion. Diabet Metab. 2005;31(4 Pt 1):391–400.

    Article  CAS  Google Scholar 

  • Chao SC, Lee JY. Brittle nails and dyspareunia as first clues to recurrences of malignant gluca-gonoma. Br J Dermatol. 2002;146(6):1071–4.

    Article  PubMed  Google Scholar 

  • Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses. 1996;46(4):348–50.

    Article  PubMed  CAS  Google Scholar 

  • Dahl PR, Zalla MJ, Winkelmann RK. Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol. 1996;35(4):523–8.

    Article  PubMed  CAS  Google Scholar 

  • De la Torre C, Losada A, Cruces MJ. Necrobiosis lipoidica: a case with prominent cholesterol clefting and transepithelial elimination. Am J Dermatopathol. 1999;21(6):575–7.

    Article  PubMed  Google Scholar 

  • Del Olmo MI, Campos V, Abellán P, Merino-Torres JF, Piñón F. A case of lipoatrophy with insulin detemir. Diabetes Res Clin Pract. 2008;80(1):e20–1.

    Article  PubMed  Google Scholar 

  • Diris N, Colomb M, Leymarie F, Durlach V, Caron J, Bernard P. Dermatoses non infectieuses au cours du diabète sucré: étude prospective de 308 malades. Ann Dermatol Venereol. 2003;130(11): 1009–14.

    PubMed  CAS  Google Scholar 

  • Eberlein-Konig B, Vogel M, Katzer K, Hein R, Kohn FM, Ring J, Abeck D. Successful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol. 2005;19(2):203–4.

    Article  PubMed  CAS  Google Scholar 

  • Edney JA, Hofmann S, Thompson JS, Kessinger A. Glucagonoma syndrome is an underdiagnosed clinical entity. Am J Surg. 1990;160(6):625–8.

    Article  PubMed  CAS  Google Scholar 

  • El Rassi Z, Partensky C, Valette PJ, Berger F, Chayvialle JA. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases. Eur J Surg Oncol. 1998;24(6):562–7.

    Article  PubMed  CAS  Google Scholar 

  • Elsborg L, Glenthoj A. Effect of somatostatin in necrolytic migratory erythema of glucagonoma. Acta Med Scand. 1985;218(2):245–9.

    PubMed  CAS  Google Scholar 

  • Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH Jr. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes. Diabetes Care. 2003;26:89–96.

    Article  PubMed  CAS  Google Scholar 

  • Foss NT, Polon D P, Takada MH, Foss-Freitas MC, Foss MC. Skin lesions in diabetic patients. Rev Saude Publica. 2005;39(4):677–82.

    Article  PubMed  CAS  Google Scholar 

  • Franchimont C, Pierard GE, Luyckx AS, Gerard J, Lapiere CM. Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide. Am J Dermatopathol. 1982;4(6):485–95.

    Article  PubMed  CAS  Google Scholar 

  • Frykberg RG. An evidence-based approach to diabetic foot infections. Am J Surg. 2003;186(5A): 44S–54S

    Article  PubMed  Google Scholar 

  • Gebauer K, Armstrong M. Koebner phenomenon with necrobiosis lipoidica diabeticorum. Int J Dermatol. 1993;32(12):895–6.

    Article  PubMed  CAS  Google Scholar 

  • Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T, Longoria L, Giurini JM, Freeman J, Khaodhiar L, Veves A. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005;366(9498):1711–7.

    Article  PubMed  CAS  Google Scholar 

  • Gudi VS, Campbell S, Gould DJ, Marshall R. Squamous cell carcinoma in an area of necrobiosis lipoidica diabeticorum: a case report. Clin Exp Dermatol. 2000;25(8):597–9.

    Article  PubMed  CAS  Google Scholar 

  • Haustein U F. Scleroderma and pseudo-scleroderma: uncommon presentations. Clin Dermatol. 2005;23(5):480–90.

    Article  PubMed  Google Scholar 

  • Hunt SJ, Narus VT, Abell E. Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis. J Am Acad Dermatol. 1991;24(3):473–7.

    Article  PubMed  CAS  Google Scholar 

  • Hussein S F, Siddique H, Coates P, Green J. Lipoatrophy is a thing of the past, or is it? Diabet Med. 2007;24(12):1470–2.

    Article  PubMed  CAS  Google Scholar 

  • Jacob N, Gleichmann U, Stadler R. Sclerödema adultorum Buschke bei secundärem Hyperpar-athyroidismus. Hautarzt. 2002;53(2):121–5.

    Article  PubMed  CAS  Google Scholar 

  • Johnson SM, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol. 2003;49(2):325–8.

    Article  PubMed  Google Scholar 

  • Kasper CS, McMurry K. Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis? J Am Acad Dermatol. 1991;25(3):534–41.

    Article  PubMed  CAS  Google Scholar 

  • Katz R, Fischmann AB, Galotto J, Guccio JG, Higgins GA, Ortega LG, West WH, Recant L. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma. Cancer. 1979;44(2):558–63.

    Article  PubMed  CAS  Google Scholar 

  • Kheir SM, Omura E F, Grizzle WE, Herrera GA, Lee I. Histologic variation in the skin lesions of the glucagonoma syndrome. Am J Surg Pathol. 1986;10(7):445–53.

    Article  PubMed  CAS  Google Scholar 

  • Kiziltan ME, Benbir G, Akalin MA. Is diabetic dermopathy a sign for severe neuropathy in patients with diabetes mellitus? Nerve conduction studies and symptom analysis. Clin Neurophysiol. 2006;117(8):1862–9.

    Article  PubMed  CAS  Google Scholar 

  • Kovacs RK, Korom I, Dobozy A, Farkas G, Ormos J, Kemeny L. Necrolytic migratory erythema. J Cutan Pathol. 2006;33(3):242–5.

    Article  PubMed  Google Scholar 

  • Kreuter A, Knierim C, Stücker M, Pawlak F et al. Fumaric acid esters in necrobiosis lipoidica: results of a prospective, non-controlled study. Br J Dermatol. 2005;153 (4):802–7

    Article  PubMed  CAS  Google Scholar 

  • Lamba S, Krishtul A, Tan MH, Lebwohl MG. Acanthosis nigricans in a plaque of scleredema on the back of a diabetic patient: a case report. Int J Dermatol. 2005;44(1):45–7.

    Article  PubMed  Google Scholar 

  • Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol. 2002;82(2):114–7.

    Article  PubMed  Google Scholar 

  • Linana JJ, Montoro FJ, Hernandez MD, Basomba A. Adverse reactions to insulin. An Med Interna. 1997;14(7):369–72.

    PubMed  CAS  Google Scholar 

  • Long CC, Laidler P, Holt PJ. Suprabasal acantholysis–an unusual feature of necrolytic migratory erythema. Clin Exp Dermatol. 1993;18(5):464–7.

    Article  PubMed  CAS  Google Scholar 

  • Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB. Human insulin analog– induced lipoatrophy. Diabetes Care. 2008;31(3):442–4.

    Article  PubMed  Google Scholar 

  • Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. Lancet. 1974;2(7871):1–5.

    Article  PubMed  CAS  Google Scholar 

  • Marinkovich M P, Botella R, Datloff J, Sangueza O P. Necrolytic migratory erythema without gluca-gonoma in patients with liver disease. J Am Acad Dermatol. 1995;32(4):604–9.

    Article  PubMed  CAS  Google Scholar 

  • McFadden N, Ree K, Søyland E, Larsen TE. Scleredema adultorum associated with a monoclonal gammopathy and generalized hyperpigmentation. Arch Dermatol. 1987;123(5):629–32.

    Article  PubMed  CAS  Google Scholar 

  • McIntosh BC, Lahinjani S, Narayan D. Necrobiosis lipoidica resulting in squamous cell carcinoma. Conn Med. 2005;69(7):401–3.

    PubMed  Google Scholar 

  • Mendonca DA, Cosker T, Makwana NK. Vacuum-assisted closure to aid wound healing in foot and ankle surgery. Foot Ankle Int. 2005;26(9):761–6.

    PubMed  Google Scholar 

  • Mullans EA, Cohen PR. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol. 1998;38 (5 Pt 2):866–73.

    Article  PubMed  CAS  Google Scholar 

  • Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol. 2005;6(4):225–37.

    Article  PubMed  Google Scholar 

  • Nguyen K, Washenik K, Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol. 2002;46(2 Suppl Case Reports):S34–6.

    Article  PubMed  Google Scholar 

  • Ossowski B, Baum C. Das Pseudoglucagonom-Syndrome. Hautarzt. 1995;46(3):173–6.

    Article  PubMed  CAS  Google Scholar 

  • Parmar RC, Bavdekar SB, Bansal S, Doraiswamy A, Khambadkone S. Scleredema adultorum. J Postgrad Med. 2000;46(2):91–3.

    PubMed  CAS  Google Scholar 

  • Perniciaro C, Rappaport KD, White JW Jr. Apoptosis with positive direct immunofluorescence findings in a patient with necrolytic migratory erythema. Cutis. 1998;62(3):129–32.

    PubMed  CAS  Google Scholar 

  • Pinzur M, Freeland R, Juknelis D. The association between body mass index and foot disorders in diabetic patients. Foot Ankle Int. 2005;26(5):375–7.

    PubMed  Google Scholar 

  • Radermecker R P, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21–8.

    Article  PubMed  Google Scholar 

  • Raile K, Noelle V, Landgraf R, Schwarz H P. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocri-nol Diabet. 2001;109(8):393–6.

    Article  CAS  Google Scholar 

  • Rallis E, Korfitis C, Gregoriou S, Rigopoulos D. Assigning new roles to topical tacrolimus. Expert Opin Investig Drugs. 2007;16(8):1267–76.

    Article  PubMed  CAS  Google Scholar 

  • Ramos AJ, Farias MA. Human insulin-induced lipoatrophy: a successful treatment with glucocor-ticoid. Diabetes Care. 2006;29(4):926–7.

    Article  PubMed  Google Scholar 

  • Rappersberger K, Wolff-Schreiner E, Konrad K, Wolff K. Das Glucagonom-Syndrom. Hautarzt. 1987;38(10):589–98.

    PubMed  CAS  Google Scholar 

  • Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661–7.

    Article  PubMed  Google Scholar 

  • Robbins JM. Treatment of onychomycosis in the diabetic patient population. J Diabetes Complications. 2003;17(2):98–104.

    Article  PubMed  Google Scholar 

  • Romano G, Moretti G, Di Benedetto A, Giofre C, Di Cesare E, Russo G, Califano L, Cucinotta D. Skin lesions in diabetes mellitus: prevalence and clinical correlations. Diabetes Res Clin Pract. 1998;39(2):101–6.

    Article  PubMed  CAS  Google Scholar 

  • Shemer A, Bergman R, Linn S, Kantor Y, Friedman-Birnbaum R. Diabetic dermopathy and internal complications in diabetes mellitus. Int J Dermatol. 1998;37(2):113–5.

    Article  PubMed  CAS  Google Scholar 

  • Shimizu I, Furuya K, Osawa H, Fujii Y, Makino H. 10a-65: a case of insulin-induced localized lobular panniculitis with evidence for the phagocytosis of insulin by histiocytes. Endocr J. 2007;54(3):477–80.

    Article  PubMed  Google Scholar 

  • Smith A P, Doolas A, Staren ED. Rapid resolution of necrolytic migratory erythema after gluca-gonoma resection. J Surg Oncol. 1996;61(4):306–9.

    Article  PubMed  CAS  Google Scholar 

  • Tanner M, Brasch J, Christophers E. Erythema necroticans migrans ohne Glucagonom. Hautarzt. 1994;45(7):480–3.

    Article  PubMed  CAS  Google Scholar 

  • Technau K, Renkl A, Norgauer J, Ziemer M. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma. Eur J Dermatol. 2005;15(2):110–2.

    PubMed  Google Scholar 

  • Tierney E P, Badger J. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature. MedGenMed. 2004;6(3):4.

    PubMed  Google Scholar 

  • Tokura Y, Mizushima Y, Hata M, Takigawa M. Necrobiosis lipoidica of the glans penis. J Am Acad Dermatol. 2003;49(5):921–4.

    Article  PubMed  Google Scholar 

  • Tom WL, Peng DH, Allaei A, Hsu D, Hata TR. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Arch Dermatol. 2005;141(11):1373–7.

    Article  PubMed  CAS  Google Scholar 

  • Truhan A P, Roenigk Jr. HH. The cutaneous mucinoses. J Am Acad Dermatol. 1986;14(1):1–18.

    Article  PubMed  CAS  Google Scholar 

  • Tuchinda C, Kerr HA, Taylor CR, Jacobe H, Bergamo BM, Elmets C, Rivard J, Lim HW. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photoder-matol Photoimmunol Photomed. 2006;22(5):247–53.

    Article  PubMed  Google Scholar 

  • van Beek A P, de Haas ER, van Vloten WA, Lips CJ, Roijers JF, Canninga-van Dijk MR. The glu-cagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004;151(5):531–7.

    Article  PubMed  Google Scholar 

  • Venencie PY, Powell FC, Su W P, Perry HO. Scleredema: a review of thirty-three cases. J Am Acad Dermatol. 1984;11(1):128–34.

    Article  PubMed  CAS  Google Scholar 

  • Vijayasingam SM, Thai AC, Chan HL. Non-infective skin associations of diabetes mellitus. Ann Acad Med Singapore. 1988;17(4):526–35.

    PubMed  CAS  Google Scholar 

  • Wee SA, Possick P. Necrobiosis lipoidica. Dermatol Online J. 2004;10(3):18.

    PubMed  Google Scholar 

  • Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore). 1996;75(2):53–63.

    Article  CAS  Google Scholar 

  • Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol. 2004;140(10):1248–50.

    Article  PubMed  Google Scholar 

  • Wonders J, Eekhoff EM, Heine R, Bruynzeel D P, Rustemeyer T. Insulin allergy: background, diagnosis and treatment. Ned Tijdschr Geneeskd. 2005;149(50):2783–8.

    PubMed  CAS  Google Scholar 

  • Yokoyama H, Fukumoto S, Koyama H, Emoto M, Kitagawa Y, Nishizawa Y. Insulin allergy; desensiti-zation with crystalline zinc-insulin and steroid tapering. Diabetes Res Clin Pract. 2003;61(3): 161–6.

    Article  PubMed  CAS  Google Scholar 

  • Yosipovitch G, Hodak E, Vardi P, Shraga I, Karp M, Sprecher E, David M. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998;21(4):506–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2009). Diabetes Mellitus and Glucagonoma. In: Cutaneous Manifestations of Endocrine Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88367-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-88367-8_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-88366-1

  • Online ISBN: 978-3-540-88367-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation